Single Dose Study of SHR4640 in Healthy Subjects

NCT02815839 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout; Hyperuricemia

Interventions

DRUG: SHR4640
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.